NeoGenomics (NEO)
NASDAQ:NEO
Holding NEO?
Track your performance easily

NeoGenomics (NEO) Financial Statements

1,765 Followers

NeoGenomics Financial Overview

NeoGenomics's market cap is currently ―. The company's EPS TTM is $-0.623; its P/E ratio is -25.93; NeoGenomics is scheduled to report earnings on October 29, 2024, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 164.50M$ 156.24M$ 155.55M$ 151.95M$ 146.92M
Gross Profit$ 72.49M$ 65.47M$ 67.59M$ 62.31M$ 59.89M
EBIT$ -19.02M$ -26.00M$ -1.55M$ -24.29M$ -29.16M
EBITDA$ -183.00K$ -7.00M$ 17.54M$ -5.44M$ -10.19M
Net Income Common Stockholders$ -18.64M$ -27.06M$ -14.33M$ -18.52M$ -24.33M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 387.86M$ 384.83M$ 415.20M$ 402.26M$ 409.35M
Total Assets$ 1.64B$ 1.64B$ 1.68B$ 1.68B$ 1.70B
Total Debt$ 606.52M$ 608.18M$ 611.68M$ 605.70M$ 609.59M
Net Debt$ 218.66M$ 223.35M$ 196.48M$ 203.44M$ 200.24M
Total Liabilities$ 727.39M$ 716.93M$ 739.69M$ 730.81M$ 738.92M
Stockholders Equity$ 915.88M$ 923.41M$ 941.54M$ 947.43M$ 956.19M
Cash Flow-
Free Cash Flow$ 814.00K$ -31.50M$ 10.73M$ -9.77M$ -9.04M
Operating Cash Flow$ 13.89M$ -25.91M$ 17.78M$ -5.50M$ -1.55M
Investing Cash Flow$ 7.31M$ 14.53M$ 17.20M$ 20.82M$ 14.95M
Financing Cash Flow$ 1.97M$ 816.00K$ 1.27M$ 1.84M$ 64.00K
Currency in USD

NeoGenomics Earnings and Revenue History

NeoGenomics Debt to Assets

NeoGenomics Cash Flow

NeoGenomics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis